文献速递慢性静脉疾病

静脉内热诱导血栓形成(EHIT)的消退时间及影响因素

Resolution times of endovenous heat-induced thrombosis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-04-19

本研究回顾性分析了2012年3月至2018年9月间3218例患者共10029例次下肢静脉内热消融术,其中射频消融(RFA)6091例次、静脉内激光消融(EVLA)3938例次,术后超声随访发现186例发生EHIT。

要点

  • EVLA术后EHIT平均消退时间75天,RFA术后139.8天,差异有统计学意义。
  • EHIT消退时间与年龄、性别、BMI、临床分级、侧别、静脉类型及氯吡格雷使用无关。
  • 术后需规律超声随访监测EHIT及再通情况。

核心结论

  • EHIT消退时间可能与EVLA和RFA治疗方式差异有关,EVLA术后EHIT消退更快。

研究设计与样本

  • 回顾性分析2012年3月至2018年9月共10029例次下肢静脉内热消融术,涉及3218例患者,其中RFA 6091例次、EVLA 3938例次。
  • 术后3至7天、第一年每3个月、之后每6至12个月行静脉双功超声评估EHIT及再通。

主要发现

  • 186例患者发生EHIT,其中RFA组109例、EVLA组77例。
  • EVLA组EHIT患者平均年龄59.97±11.61岁,RFA组平均年龄73.4±9.64岁。
  • EVLA组EHIT平均消退时间75±71.97天,RFA组139.8±232.52天。
  • EHIT消退时间与年龄、性别、BMI、临床分级、侧别、治疗静脉类型及围术期氯吡格雷使用无统计学差异。

临床怎么用

  • 对于EVLA或RFA术后发生EHIT的患者,应知晓EVLA术后EHIT可能消退更快。
  • 术后按计划行静脉双功超声随访,监测EHIT消退及再通情况。

局限性

  • 本研究为回顾性分析,可能存在选择偏倚。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lower extremity endovenous ablation has become the primary treatment modality for symptomatic venous reflux disease. Endovenous heat-induced thrombosis (EHIT) has been reported as one of the primary complications of these venous ablative procedures. Our aim was to determine how long EHITs take to resolve and the factors affecting this length of time. METHODS: A retrospective analysis was performed of 10,029 consecutive procedures from March 2012 to September 2018 performed on 3218 patients who underwent endovenous ablation for lower extremity venous reflux. There were 6091 procedures performed with radiofrequency ablation (RFA) and 3938 with endovenous laser ablation (EVLA). Postprocedural venous duplex ultrasound was performed to evaluate for EHIT and recanalization at 3 to 7 days, every 3 months for the first year, and every 6 to 12 months thereafter. JMP version 14 (SAS Institute, Cary, NC) was used for all statistical analysis. RESULTS: EHIT was found to have developed in 186 patients; 109 patients had been treated with RFA and 77 with EVLA. The average age of the patients receiving EVLA in whom EHIT developed was 59.97 ± 11.61 years. The patients who received RFA and in whom EHIT developed had an average age of 73.4 ± 9.64 years. The average time of resolution for the EVLA group was 75 ± 71.97 days. The average resolution time for the RFA group was 139.8 ± 232.52 days. There were no statistical differences between EHIT resolution times and age, sex, body mass index, clinical class, laterality, type of vein treated, or whether the patient was taking clopidogrel preoperatively or postoperatively. A statistical difference was found between EHIT resolution time and whether the patient was treated with EVLA or RFA (P = .0332). CONCLUSIONS: Our study seems to suggest that EHIT resolution times may be related to the difference in treatment modality between EVLA and RFA. The data suggest that EHIT resolves more quickly with the use of EVLA than with RFA.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Kibrik P, Chait J, Arustamyan M, et al. Resolution times of endovenous heat-induced thrombosis. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32321690. doi:10.1016/j.jvsv.2020.02.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。